nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—NR3C1—polycystic ovary syndrome	0.905	1	CbGaD
Methylprednisolone—NR3C1—urine—polycystic ovary syndrome	0.00355	0.191	CbGeAlD
Methylprednisolone—CYP3A4—urine—polycystic ovary syndrome	0.00269	0.145	CbGeAlD
Methylprednisolone—Fungal infection—Metformin—polycystic ovary syndrome	0.0016	0.0601	CcSEcCtD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00142	0.0399	CbGpPWpGaD
Methylprednisolone—ABCB1—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.00118	0.0331	CbGpPWpGaD
Methylprednisolone—Neuropathy—Metformin—polycystic ovary syndrome	0.00116	0.0436	CcSEcCtD
Methylprednisolone—NR3C1—embryo—polycystic ovary syndrome	0.00115	0.0618	CbGeAlD
Methylprednisolone—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000988	0.0687	CrCbGaD
Methylprednisolone—Injury—Metformin—polycystic ovary syndrome	0.000974	0.0367	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—INSR—polycystic ovary syndrome	0.000945	0.0266	CbGpPWpGaD
Methylprednisolone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000941	0.0506	CbGeAlD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—polycystic ovary syndrome	0.000873	0.0245	CbGpPWpGaD
Methylprednisolone—NR3C1—endometrium—polycystic ovary syndrome	0.00084	0.0452	CbGeAlD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—polycystic ovary syndrome	0.000821	0.0231	CbGpPWpGaD
Methylprednisolone—Breast disorder—Metformin—polycystic ovary syndrome	0.000809	0.0304	CcSEcCtD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.000789	0.0222	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—polycystic ovary syndrome	0.000788	0.0221	CbGpPWpGaD
Methylprednisolone—Abdominal distension—Metformin—polycystic ovary syndrome	0.000779	0.0293	CcSEcCtD
Methylprednisolone—NR3C1—uterus—polycystic ovary syndrome	0.000774	0.0417	CbGeAlD
Methylprednisolone—NR3C1—pituitary gland—polycystic ovary syndrome	0.000761	0.0409	CbGeAlD
Methylprednisolone—Pancreatitis—Metformin—polycystic ovary syndrome	0.000759	0.0285	CcSEcCtD
Methylprednisolone—NR3C1—adipose tissue—polycystic ovary syndrome	0.000757	0.0407	CbGeAlD
Methylprednisolone—Sweating increased—Metformin—polycystic ovary syndrome	0.000754	0.0284	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—SLC2A4—polycystic ovary syndrome	0.000744	0.0209	CbGpPWpGaD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000709	0.0199	CbGpPWpGaD
Methylprednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—polycystic ovary syndrome	0.000702	0.0197	CbGpPWpGaD
Methylprednisolone—Infestation—Metformin—polycystic ovary syndrome	0.00069	0.026	CcSEcCtD
Methylprednisolone—Infestation NOS—Metformin—polycystic ovary syndrome	0.00069	0.026	CcSEcCtD
Methylprednisolone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000679	0.0366	CbGeAlD
Methylprednisolone—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000677	0.0255	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—polycystic ovary syndrome	0.000635	0.0178	CbGpPWpGaD
Methylprednisolone—NR3C1—female gonad—polycystic ovary syndrome	0.000634	0.0341	CbGeAlD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.000633	0.0178	CbGpPWpGaD
Methylprednisolone—Bradycardia—Metformin—polycystic ovary syndrome	0.000631	0.0237	CcSEcCtD
Methylprednisolone—NR3C1—vagina—polycystic ovary syndrome	0.00063	0.0339	CbGeAlD
Methylprednisolone—Rhinitis—Metformin—polycystic ovary syndrome	0.000621	0.0234	CcSEcCtD
Methylprednisolone—ABCB1—embryo—polycystic ovary syndrome	0.000615	0.0331	CbGeAlD
Methylprednisolone—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000609	0.0229	CcSEcCtD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000608	0.0171	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—LIFR—polycystic ovary syndrome	0.000595	0.0167	CbGpPWpGaD
Methylprednisolone—NR3C1—endocrine gland—polycystic ovary syndrome	0.000589	0.0317	CbGeAlD
Methylprednisolone—Eye disorder—Metformin—polycystic ovary syndrome	0.000579	0.0218	CcSEcCtD
Methylprednisolone—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000575	0.0216	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000565	0.0159	CbGpPWpGaD
Methylprednisolone—Angiopathy—Metformin—polycystic ovary syndrome	0.000562	0.0211	CcSEcCtD
Methylprednisolone—Immune system disorder—Metformin—polycystic ovary syndrome	0.00056	0.0211	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000558	0.021	CcSEcCtD
Methylprednisolone—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000548	0.0381	CrCbGaD
Methylprednisolone—Malnutrition—Metformin—polycystic ovary syndrome	0.000539	0.0203	CcSEcCtD
Methylprednisolone—Erythema—Metformin—polycystic ovary syndrome	0.000539	0.0203	CcSEcCtD
Methylprednisolone—Exemestane—CYP19A1—polycystic ovary syndrome	0.000506	0.0352	CrCbGaD
Methylprednisolone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000504	0.0271	CbGeAlD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.000503	0.0141	CbGpPWpGaD
Methylprednisolone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0005	0.0188	CcSEcCtD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—polycystic ovary syndrome	0.0005	0.014	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—polycystic ovary syndrome	0.000489	0.0137	CbGpPWpGaD
Methylprednisolone—Malaise—Metformin—polycystic ovary syndrome	0.000486	0.0183	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—LIF—polycystic ovary syndrome	0.000485	0.0136	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—RETN—polycystic ovary syndrome	0.000485	0.0136	CbGpPWpGaD
Methylprednisolone—Syncope—Metformin—polycystic ovary syndrome	0.000484	0.0182	CcSEcCtD
Methylprednisolone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000483	0.0336	CrCbGaD
Methylprednisolone—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000474	0.0178	CcSEcCtD
Methylprednisolone—Hypertension—Metformin—polycystic ovary syndrome	0.000466	0.0175	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—NAMPT—polycystic ovary syndrome	0.000463	0.013	CbGpPWpGaD
Methylprednisolone—Myalgia—Metformin—polycystic ovary syndrome	0.000459	0.0173	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000456	0.0172	CcSEcCtD
Methylprednisolone—Discomfort—Metformin—polycystic ovary syndrome	0.000454	0.0171	CcSEcCtD
Methylprednisolone—ABCB1—endometrium—polycystic ovary syndrome	0.00045	0.0242	CbGeAlD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000447	0.0125	CbGpPWpGaD
Methylprednisolone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000446	0.024	CbGeAlD
Methylprednisolone—NR3C1—Nuclear Receptors—AR—polycystic ovary syndrome	0.000439	0.0123	CbGpPWpGaD
Methylprednisolone—Infection—Metformin—polycystic ovary syndrome	0.000437	0.0165	CcSEcCtD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.000437	0.0123	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—polycystic ovary syndrome	0.000437	0.0123	CbGpPWpGaD
Methylprednisolone—Shock—Metformin—polycystic ovary syndrome	0.000433	0.0163	CcSEcCtD
Methylprednisolone—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000432	0.0162	CcSEcCtD
Methylprednisolone—Skin disorder—Metformin—polycystic ovary syndrome	0.000428	0.0161	CcSEcCtD
Methylprednisolone—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000427	0.012	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—polycystic ovary syndrome	0.000426	0.012	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000426	0.016	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000425	0.0119	CbGpPWpGaD
Methylprednisolone—ABCB1—uterus—polycystic ovary syndrome	0.000415	0.0223	CbGeAlD
Methylprednisolone—Hypotension—Metformin—polycystic ovary syndrome	0.000411	0.0155	CcSEcCtD
Methylprednisolone—ABCB1—pituitary gland—polycystic ovary syndrome	0.000407	0.0219	CbGeAlD
Methylprednisolone—ABCB1—adipose tissue—polycystic ovary syndrome	0.000405	0.0218	CbGeAlD
Methylprednisolone—Difluprednate—NR3C1—polycystic ovary syndrome	0.000404	0.0281	CrCbGaD
Methylprednisolone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000401	0.0151	CcSEcCtD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.000399	0.0112	CbGpPWpGaD
Methylprednisolone—Paraesthesia—Metformin—polycystic ovary syndrome	0.000395	0.0149	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—polycystic ovary syndrome	0.000392	0.011	CbGpPWpGaD
Methylprednisolone—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000391	0.0272	CrCbGaD
Methylprednisolone—Clocortolone—NR3C1—polycystic ovary syndrome	0.000391	0.0272	CrCbGaD
Methylprednisolone—Dyspepsia—Metformin—polycystic ovary syndrome	0.000388	0.0146	CcSEcCtD
Methylprednisolone—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.000382	0.0107	CbGpPWpGaD
Methylprednisolone—Fatigue—Metformin—polycystic ovary syndrome	0.00038	0.0143	CcSEcCtD
Methylprednisolone—Diflorasone—NR3C1—polycystic ovary syndrome	0.00037	0.0257	CrCbGaD
Methylprednisolone—Desonide—NR3C1—polycystic ovary syndrome	0.00037	0.0257	CrCbGaD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000369	0.0104	CbGpPWpGaD
Methylprednisolone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000364	0.0196	CbGeAlD
Methylprednisolone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000363	0.0136	CcSEcCtD
Methylprednisolone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000361	0.0251	CrCbGaD
Methylprednisolone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00036	0.0135	CcSEcCtD
Methylprednisolone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000357	0.0248	CrCbGaD
Methylprednisolone—Fludrocortisone—AR—polycystic ovary syndrome	0.000352	0.0245	CrCbGaD
Methylprednisolone—Urticaria—Metformin—polycystic ovary syndrome	0.00035	0.0132	CcSEcCtD
Methylprednisolone—Abdominal pain—Metformin—polycystic ovary syndrome	0.000348	0.0131	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—AR—polycystic ovary syndrome	0.000347	0.00976	CbGpPWpGaD
Methylprednisolone—ABCB1—female gonad—polycystic ovary syndrome	0.000339	0.0182	CbGeAlD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000337	0.00948	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000337	0.00948	CbGpPWpGaD
Methylprednisolone—ABCB1—vagina—polycystic ovary syndrome	0.000337	0.0181	CbGeAlD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—AR—polycystic ovary syndrome	0.000337	0.00946	CbGpPWpGaD
Methylprednisolone—Medrysone—NR3C1—polycystic ovary syndrome	0.000328	0.0228	CrCbGaD
Methylprednisolone—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000316	0.022	CrCbGaD
Methylprednisolone—Asthenia—Metformin—polycystic ovary syndrome	0.000316	0.0119	CcSEcCtD
Methylprednisolone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000315	0.017	CbGeAlD
Methylprednisolone—Pruritus—Metformin—polycystic ovary syndrome	0.000311	0.0117	CcSEcCtD
Methylprednisolone—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000311	0.0216	CrCbGaD
Methylprednisolone—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000306	0.0213	CrCbGaD
Methylprednisolone—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000306	0.0213	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000304	0.0212	CrCbGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TH—polycystic ovary syndrome	0.000303	0.00851	CbGpPWpGaD
Methylprednisolone—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.000302	0.021	CrCbGaD
Methylprednisolone—Diarrhoea—Metformin—polycystic ovary syndrome	0.000301	0.0113	CcSEcCtD
Methylprednisolone—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.000301	0.0209	CrCbGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TCF7L2—polycystic ovary syndrome	0.0003	0.00842	CbGpPWpGaD
Methylprednisolone—Dizziness—Metformin—polycystic ovary syndrome	0.000291	0.011	CcSEcCtD
Methylprednisolone—NR3C1—Circadian Clock—NCOR1—polycystic ovary syndrome	0.000286	0.00803	CbGpPWpGaD
Methylprednisolone—Budesonide—NR3C1—polycystic ovary syndrome	0.000284	0.0198	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.000284	0.0198	CrCbGaD
Methylprednisolone—Vomiting—Metformin—polycystic ovary syndrome	0.00028	0.0105	CcSEcCtD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB1—polycystic ovary syndrome	0.00028	0.00786	CbGpPWpGaD
Methylprednisolone—Rash—Metformin—polycystic ovary syndrome	0.000278	0.0104	CcSEcCtD
Methylprednisolone—Dermatitis—Metformin—polycystic ovary syndrome	0.000277	0.0104	CcSEcCtD
Methylprednisolone—Betamethasone—PGR—polycystic ovary syndrome	0.000276	0.0192	CrCbGaD
Methylprednisolone—Headache—Metformin—polycystic ovary syndrome	0.000276	0.0104	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000275	0.00773	CbGpPWpGaD
Methylprednisolone—Mometasone—NR3C1—polycystic ovary syndrome	0.000271	0.0188	CrCbGaD
Methylprednisolone—Rimexolone—NR3C1—polycystic ovary syndrome	0.000267	0.0186	CrCbGaD
Methylprednisolone—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.000263	0.0074	CbGpPWpGaD
Methylprednisolone—Nausea—Metformin—polycystic ovary syndrome	0.000261	0.00984	CcSEcCtD
Methylprednisolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—polycystic ovary syndrome	0.000253	0.00712	CbGpPWpGaD
Methylprednisolone—Fluocinonide—NR3C1—polycystic ovary syndrome	0.000252	0.0175	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000251	0.00706	CbGpPWpGaD
Methylprednisolone—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000249	0.0173	CrCbGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—PRL—polycystic ovary syndrome	0.000248	0.00696	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—polycystic ovary syndrome	0.000246	0.0069	CbGpPWpGaD
Methylprednisolone—Alclometasone—NR3C1—polycystic ovary syndrome	0.000245	0.017	CrCbGaD
Methylprednisolone—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000245	0.017	CrCbGaD
Methylprednisolone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000241	0.00676	CbGpPWpGaD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00024	0.00675	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—polycystic ovary syndrome	0.00024	0.00674	CbGpPWpGaD
Methylprednisolone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000239	0.0166	CrCbGaD
Methylprednisolone—Flunisolide—NR3C1—polycystic ovary syndrome	0.000239	0.0166	CrCbGaD
Methylprednisolone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000239	0.0166	CrCbGaD
Methylprednisolone—Paramethasone—NR3C1—polycystic ovary syndrome	0.000236	0.0164	CrCbGaD
Methylprednisolone—NR3C1—Adipogenesis—NAMPT—polycystic ovary syndrome	0.000232	0.00653	CbGpPWpGaD
Methylprednisolone—Ciclesonide—NR3C1—polycystic ovary syndrome	0.000232	0.0161	CrCbGaD
Methylprednisolone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.00023	0.016	CrCbGaD
Methylprednisolone—NR3C1—Adipogenesis—LMNA—polycystic ovary syndrome	0.00022	0.00619	CbGpPWpGaD
Methylprednisolone—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000219	0.00616	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000218	0.00611	CbGpPWpGaD
Methylprednisolone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000217	0.0151	CrCbGaD
Methylprednisolone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000217	0.0151	CrCbGaD
Methylprednisolone—ABCB1—Allograft Rejection—FOXP3—polycystic ovary syndrome	0.000215	0.00603	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000213	0.0148	CrCbGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.00021	0.00589	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—BAX—polycystic ovary syndrome	0.000202	0.00568	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000202	0.014	CrCbGaD
Methylprednisolone—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000201	0.00566	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—TFRC—polycystic ovary syndrome	0.000195	0.00548	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000194	0.00544	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—ADIPOQ—polycystic ovary syndrome	0.00019	0.00534	CbGpPWpGaD
Methylprednisolone—Betamethasone—CYP19A1—polycystic ovary syndrome	0.00019	0.0132	CrCbGaD
Methylprednisolone—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000188	0.013	CrCbGaD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000186	0.00523	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000185	0.00519	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—SERPINE1—polycystic ovary syndrome	0.000185	0.00518	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—polycystic ovary syndrome	0.000183	0.00513	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SLC2A4—polycystic ovary syndrome	0.00018	0.00505	CbGpPWpGaD
Methylprednisolone—Prednisone—NR3C1—polycystic ovary syndrome	0.00017	0.0118	CrCbGaD
Methylprednisolone—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000169	0.0118	CrCbGaD
Methylprednisolone—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.000168	0.0117	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000162	0.00456	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000162	0.00456	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000162	0.00454	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PGR—polycystic ovary syndrome	0.000161	0.0112	CrCbGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00016	0.00448	CbGpPWpGaD
Methylprednisolone—Prednisolone—NR3C1—polycystic ovary syndrome	0.000157	0.0109	CrCbGaD
Methylprednisolone—Betamethasone—NR3C1—polycystic ovary syndrome	0.000154	0.0107	CrCbGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—polycystic ovary syndrome	0.000147	0.00412	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—NCOR1—polycystic ovary syndrome	0.000144	0.00403	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000142	0.00399	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000141	0.00396	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000139	0.00391	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000138	0.00388	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000135	0.0038	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000132	0.00371	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000131	0.00368	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000129	0.00364	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000128	0.00361	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000123	0.00346	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IRS2—polycystic ovary syndrome	0.000121	0.00339	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00012	0.00338	CbGpPWpGaD
Methylprednisolone—Hydrocortisone—NR3C1—polycystic ovary syndrome	0.00012	0.00833	CrCbGaD
Methylprednisolone—NR3C1—Adipogenesis—LEP—polycystic ovary syndrome	0.000118	0.00332	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000114	0.00321	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—LSM5—polycystic ovary syndrome	0.000113	0.00316	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP19A1—polycystic ovary syndrome	0.00011	0.00766	CrCbGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000109	0.00307	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000106	0.00299	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IRS1—polycystic ovary syndrome	0.000105	0.00296	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000105	0.00294	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000104	0.00292	CbGpPWpGaD
Methylprednisolone—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.00291	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—polycystic ovary syndrome	0.000103	0.00289	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000102	0.00288	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—INS—polycystic ovary syndrome	0.000101	0.00284	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	9.96e-05	0.0028	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IGF1—polycystic ovary syndrome	9.76e-05	0.00274	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—SERPINE1—polycystic ovary syndrome	9.27e-05	0.0026	CbGpPWpGaD
Methylprednisolone—Dexamethasone—NR3C1—polycystic ovary syndrome	8.93e-05	0.00621	CrCbGaD
Methylprednisolone—NR3C1—Gene Expression—TEAD2—polycystic ovary syndrome	8.9e-05	0.0025	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	8.83e-05	0.00248	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	8.78e-05	0.00247	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	8.57e-05	0.00241	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.41e-05	0.00236	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.36e-05	0.00235	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	8.34e-05	0.00234	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.25e-05	0.00232	CbGpPWpGaD
Methylprednisolone—Dexamethasone—CYP1A1—polycystic ovary syndrome	8.11e-05	0.00564	CrCbGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	7.94e-05	0.00223	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	7.71e-05	0.00217	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.35e-05	0.00206	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	7.24e-05	0.00203	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	6.86e-05	0.00193	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	6.78e-05	0.0019	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	6.76e-05	0.0019	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	6.49e-05	0.00182	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	6.38e-05	0.00179	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	6.34e-05	0.00178	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.24e-05	0.00175	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	6.07e-05	0.00171	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	6e-05	0.00169	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.99e-05	0.00168	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	5.89e-05	0.00166	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.66e-05	0.00159	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.65e-05	0.00159	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.57e-05	0.00156	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	5.53e-05	0.00155	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	5.51e-05	0.00155	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.24e-05	0.00147	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	5.14e-05	0.00144	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	5.1e-05	0.00143	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.06e-05	0.00142	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	4.7e-05	0.00132	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	4.7e-05	0.00132	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.47e-05	0.00126	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	4.41e-05	0.00124	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.41e-05	0.00124	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	4.37e-05	0.00123	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	4.25e-05	0.00119	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.86e-05	0.00108	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.81e-05	0.00107	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	3.76e-05	0.00106	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	3.75e-05	0.00105	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	3.72e-05	0.00104	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	3.72e-05	0.00104	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	3.71e-05	0.00104	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.6e-05	0.00101	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.55e-05	0.000998	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.39e-05	0.000951	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.37e-05	0.000945	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.31e-05	0.000931	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.17e-05	0.00089	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	3.12e-05	0.000875	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.08e-05	0.000865	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.95e-05	0.00083	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.9e-05	0.000814	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.9e-05	0.000814	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	2.89e-05	0.000811	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.82e-05	0.000792	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.82e-05	0.000791	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.69e-05	0.000757	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.69e-05	0.000754	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	2.52e-05	0.000709	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.52e-05	0.000707	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.51e-05	0.000706	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.4e-05	0.000673	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.36e-05	0.000664	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.29e-05	0.000644	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.29e-05	0.000644	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	2.18e-05	0.000614	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	2.14e-05	0.0006	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	2.07e-05	0.000581	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.92e-05	0.000539	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.9e-05	0.000535	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.84e-05	0.000518	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.82e-05	0.000511	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.81e-05	0.000508	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.78e-05	0.000499	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.74e-05	0.000488	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.71e-05	0.00048	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.69e-05	0.000474	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.63e-05	0.000458	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.59e-05	0.000447	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.57e-05	0.00044	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.55e-05	0.000435	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.48e-05	0.000415	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.36e-05	0.000381	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.35e-05	0.000378	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.32e-05	0.000371	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.32e-05	0.00037	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.27e-05	0.000358	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.24e-05	0.000348	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.17e-05	0.000329	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.14e-05	0.000319	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	1.11e-05	0.000311	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.09e-05	0.000308	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.05e-05	0.000296	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.05e-05	0.000295	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.04e-05	0.000292	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1e-05	0.000281	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	9.81e-06	0.000276	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	9.66e-06	0.000271	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	9.32e-06	0.000262	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	8.35e-06	0.000235	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	8.13e-06	0.000228	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	7.64e-06	0.000215	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	7.56e-06	0.000212	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	7.45e-06	0.000209	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—INS—polycystic ovary syndrome	7.41e-06	0.000208	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	6.82e-06	0.000192	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	6.5e-06	0.000183	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	6.16e-06	0.000173	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	5.74e-06	0.000161	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.66e-06	0.000131	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	4.59e-06	0.000129	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	4.57e-06	0.000128	CbGpPWpGaD
